View More
In this CME-certified video module, Keith C. Ferdinand, MD, FACC, FAHA, discusses approaches to recognizing patients with elevated HF risk, using biomarkers to support HF diagnosis and prognosis, and integrating the latest treatment options into evidence-based management therapies, with a focus on treating special patient populations.
Keith C. Ferdinand, MD, FACC, FAHA
Physicians:
maximum of 0.75 AMA PRA Category 1 Credits™
Released: August 31, 2016
Expiration: August 30, 2017
In this downloadable slideset, Keith C. Ferdinand, MD, FACC, FAHA, reviews risk factors for HF, the use of biomarkers to support HF diagnosis and prognosis, and the latest HF treatment strategies, with a focus on treating special patient populations.
I describe how biomarkers such as BNP and NT-proBNP can help influence decisions about the diagnosis and prognosis of heart failure.
Akshay Suvas Desai, MD, MPH
Released: October 10, 2016
Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112
Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.